Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
"Hearing witnesses: Sego, Kathy, mother of a child with insulin-dependent diabetes, Madison, IN; Holtz-Eakin, Douglas, Ph.D., president, American Action Forum, Washington, DC; Miller, Mark, Ph.D., executive vice president of health care, Laura and John Arnold Foundation, Houston, TX; Bach, Peter B., M.D., director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY."--Pt. 1
"Hearing witnesses: Miller, Steve, M.D., executive vice president and chief clinical officer, Cigna Corporation, Bloomfield, CT; Rice, Derica, executive vice president, CVS Health; and president, CVS Caremark, Woonsocket, RI; Fleming, William K., Pharm.D., segment president, healthcare services, Humana, Inc., Louisville, KY; Prince, John M., chief executive officer, OptumRx, Minnetonka, MN; Kolar, Mike, interim president and CEO, Prime Therapeutics, LLC, Eagan, MN."--Pt. 3
"Serial no. 116-267"--Pt. 1.
"January 29, 2019"--Pt. 1.
"February 26, 2019"--Pt. 2.
"Serial no. 116-39"--Pt. 2.
"April 9, 2019"--Pt. 3.
"Serial no. 116-415"--Pt. 3.
Shipping list no.: 2020-0156-M (Pt. 2).
Includes bibliographical references.
Date of hearing: 2019-01-29--Pt. 1.
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2019] 1 microfiche : negative.